Antidepressants and the Risk of Suicidal Behaviors
Open Access
- 21 July 2004
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 292 (3) , 338-343
- https://doi.org/10.1001/jama.292.3.338
Abstract
In 1991 the US Food and Drug Administration (FDA) held a public meeting to address widespread concerns that a recently marketed selective serotonin reuptake inhibitor (SSRI) antidepressant, fluoxetine (Prozac), was causing severe suicidal behaviors. Dozens of attendees related personal experiences that described such behavior in relatives and friends shortly after they had started taking fluoxetine for depression.1Keywords
This publication has 4 references indexed in Scilit:
- Anti-depressants and SuicidePublished by National Bureau of Economic Research ,2007
- Validity of the General Practice Research DatabasePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2001
- Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.BMJ, 1991